Cryosurgery (also known as cryotherapy, cryoablation, or cryosurgical ablation) is a procedure in which the prostate gland is frozen under controlled conditions in order to kill cancer cells. Used for many years in the treatment of skin cancer, cryosurgery is currently considered an experimental therapy for prostate cancer because there are no long-term results to document the technique's effectiveness.
Cryosurgery works best on prostates 40 grams or less in size as measured by ultrasound. Three to six months prior to the procedure, the patient is placed on hormone therapy to block production of male hormones, which cause prostate cancer to grow. Hormone therapy shrinks the prostate and cancer prior to cryosurgery and improves the chances of freezing the entire prostate.
The procedure is performed while the patient is under either general or local anesthesia. Special metal probes are inserted through the perineum (the area between the scrotum and anus) and directly into preselected locations in the prostate gland. Liquid nitrogen is then circulated through the probes to freeze the entire gland. The goal is to create an "ice ball" large enough and cold enough to kill the cancer.
An ultrasound probe placed in the rectum guides the placement of the probes, monitors the formation of the ice ball and ensures that the rectal wall is not frozen. A warming catheter filled with a saltwater solution is placed in urethra to keep it warm during procedure. During the procedure, a Foley catheter is inserted to drain urine; it is left in place for two to three weeks. Typical hospital stays are one to two days.
Appropriate candidates for cryosurgery
Those who should consider other treatments
Side effects and complications of cryosurgery
Advantages of cryosurgery
Disadvantages of cryosurgery
1 Aboseif S, Shinohara K,
Borirakchanyavat S, Deirmenjian J, Carroll PR. The effect
of cryosurgical ablation of the prostate on erectile function.
Br J Urol 80(6):918-22.
The Prostate Cancer pages of this Web site are part of the Comprehensive Prostate Cancer Awareness Program (CPCAP), a major regional effort to reduce the rates of death and illness caused by prostate cancer in southwestern Pennsylvania. Funding for CPCAP is provided by a grant from the Commonwealth of Pennsylvania.
About This Web Site
|
Give Us Your Feedback
|
Privacy Statement
|
Disclaimer
|
Informatics Web Resources
©
UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811
|
PCI-INFO@upmc.edu
|
Send questions and comments to UPCIwebupdates@upmc.edu

